Liver Cancer Immunotherapy Cancer immunotherapy is changing the outlook for patients diagnosed with different types of liver cancer Immunotherapy for liver cancer offers some of the greatest new treatment options for patients. There are three main types of liver cancer: hepatocellular carcinoma (HCC), cholangiosarcoma, and hepatoblastoma. Rarer subtypes do occur within these categories, such as fibrolamellar hepatocellular carcinoma, which are also eligible for treatment with immunotherapy based on the individual patient’s likelihood to respond.Liver cancers are diagnosed in more than 800,000 people around the world each year and is one of the leading causes of cancer deaths globally. In this breakout session from the 2022 CRI Virtual Immunotherapy Patient Summit, Dr. Theodore Welling from the Perlmutter Cancer Center at NYU Health discusses the latest updates in immunotherapy treatments for patients with these and other types of liver cancer. Skin Cancer and Melanoma Immunotherapy Understanding and Overcoming Barriers to Accessing Cancer Care Blood Cancer Immunotherapy Breast Cancer Immunotherapy Colorectal Cancer Immunotherapy Kidney Cancer Immunotherapy Lung Cancer Immunotherapy Pancreatic Cancer Immunotherapy Prostate Cancer Immunotherapy Intro to CRI Cancer Immunotherapy Basics: Harnessing Our Immune System to Fight Cancer Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments Patient Perspectives: Immunotherapy and Clinical Trial Experiences Bladder Cancer Immunotherapy Gynecologic Cancer Immunotherapy Go back to event page Go back Hosts Tamron Hall Award-Winning TV Host, Journalist, Executive Producer, and Philanthropist CRI Experts Julie Brahmer, MD Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Andrea Cercek, MD Memorial Sloan Kettering Cancer Center Luis Diaz Jr., MD Memorial Sloan Kettering Cancer Center Peter E. Fecci, MD, PhD Duke Cancer Center, DukeHealth, and Duke University Lawrence Fong, MD UCSF Helen Diller Family Comprehensive Cancer Center Matthew D. Galsky, MD The Tisch Cancer Institute Sangeeta Goswami, MD, PhD The University of Texas MD Anderson Cancer Center Elizabeth Ann Mittendorf, MD, PhD Dana-Farber/Harvard Cancer Center Kunle Odunsi, MD, PhD University of Chicago Medicine Comprehensive Cancer Center Joseph E. Ravenell, MD Perlmutter Cancer Center NYU Langone Health Marcel van den Brink, MD, PhD Memorial Sloan Kettering Cancer Center Ana I. Velázquez Mañana, MD MSc UCSF Helen Diller Family Comprehensive Cancer Center Robert H. Vonderheide, MD, DPhil University of Pennsylvania Health System Jennifer Wargo, MD, MMSc The University of Texas MD Anderson Cancer Center Jeffrey S. Weber, MD, PhD Perlmutter Cancer Center NYU Langone Health Theodore H. Welling, MD Perlmutter Cancer Center NYU Langone Health CRI ImmunoAdvocates LaToya Bolds-Johnson, PA-C, CAQ-EM Breast Cancer Advocate & Thriver Stephen Estrada Long-term Survivor of Stage 4 Colorectal Cancer Stephanie Gangi Breast Cancer Navigator Sunshine Pegues Lung Cancer Veteran John White Prostate Cancer Veteran CRI Moderators Brian Brewer Cancer Research Institute Sponsors Gold Silver Contributor Friend Host Institutions Request a clinical trials orientation appointment Request Questions? Contact[email protected]